Current news of SHS and our portfolio companies

16 May 2022 - Press Releases

MEDTECH-INSIDE – Part 16: Germany leads in DiGA

Digital health applications (DiGA) can improve medical care.

9 May 2022 - SHS News

SHS strengthens finance team: Lukas Maucher joins Tübingen-based private equity investor as CFO

Before joining SHS, Lukas worked as a manager at one of the Big Four auditing firms in southern Germany. He completed his Bachelor of Science in Business Administration with a focus on Corporate Accounting and Finance at the LMU in Munich. He completed his Master’s degree at the University of Mannheim with a focus on […]

22 April 2022 - SHS News

SHS and yabeo invest in the leading Scandinavian digital health platform Dr.Dropin

The fast-growing Norwegian healthcare provider Dropin enables short-term medical consultation and treatment – in person on site as well as digitally via app Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years SHS invests from its fifth fund generation in the Scandinavian […]

21 April 2022 - SHS News

SHS sells shares in Bochum-based phenox GmbH, a leading manufacturer of instruments and implants for the treatment of stroke

The fast-growing MedTech company phenox specialises in instruments and implants for the neurointerventional therapy of stroke With the growth capital provided by SHS et al., the Bochum-based company has developed from a start-up into a global leader in the field of stroke therapy A successful exit for investors from the third SHS fund generation The […]

9 March 2022 - Press Releases

With capital, sector expertise, experience and a strong network, the healthcare investor SHS supports companies on their growth path.

Since 1993, the Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH has successfully developed and sold more than 68 companies from the medtech industry with capital and know-how. Read three success stories from our contribution to the Voelker brochure “Potentials MedTech 2022”, in which big names in medical technology have their say.

21 February 2022 - Press Releases

MEDTECH-INSIDE – Part 15: Frontrunner Healthcare Industry

Consistent and reliable: the healthcare sector has been the innovation engine of the German and international economy for years

15 February 2022 - SHS News

SHS sells leading enzyme engineering company c-LEcta GmbH to Kerry Group

c-LEcta was able to translate technology leadership into tremendous commercial growth during the holding period of SHS Leipzig-based c-LEcta’s clients include international corporations in the pharmaceutical, chemical and food industries. With the acquisition, Kerry Group intends to further expand the internationalization of the company in the field of enzymes Tübingen / 15.02.2022 The Tübingen-based growth […]

3 February 2022 - SHS News

Impilo and SHS acquire Lowenco

VAMDRUP, Denmark, February 3rd, 2022 – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners. Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance […]

22 December 2021 - Press Releases

Börsen-Zeitung: Many factors speak for a healthcare outperformance

As an important future and economic factor, the healthcare industry has become more visible to the public in the past 20 months. There has also been significant movement in the market for healthcare investments. In the first half of 2021, the volume of M&A activities in the DACH region increased by around 20 % compared […]

21 December 2021 - SHS News

Stability: SHS Medical Technology Index holds its own in the crisis

Medical technology market in Germany to remain at a high level in 2020, but with slight declines Pandemic leaves both positive and negative traces on medical technology companies SHS expects better development for medical technology than for the overall economy in Germany in 2021 despite Corona The new regulatory requirements (MDR) continue to burden many […]